194 related articles for article (PubMed ID: 37261660)
21. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
22. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
[No Abstract] [Full Text] [Related]
23.
Klümper N; Ralser DJ; Bawden EG; Landsberg J; Zarbl R; Kristiansen G; Toma M; Ritter M; Hölzel M; Ellinger J; Dietrich D
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234847
[TBL] [Abstract][Full Text] [Related]
24. An
Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
[TBL] [Abstract][Full Text] [Related]
25. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
Hong Y; Lin M; Ou D; Huang Z; Shen P
BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
[TBL] [Abstract][Full Text] [Related]
26. Multi-omics pan-cancer study of cuproptosis core gene
Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
Front Immunol; 2022; 13():981764. PubMed ID: 36605188
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Chen C; Sheng Y
Technol Cancer Res Treat; 2021; 20():15330338211036233. PubMed ID: 34346239
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of
Liu W; Xiao Z; Dong M; Li X; Huang Z
Oncol Lett; 2024 Mar; 27(3):97. PubMed ID: 38288038
[TBL] [Abstract][Full Text] [Related]
29. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
30. Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8
Gao H; Sun H; He A; Liu H; Zhang Z; Li D; Mao W; Qian J
Eur J Med Res; 2024 Jan; 29(1):89. PubMed ID: 38291496
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.
Yang W; Chen H; Ma L; Dong J; Wei M; Xue X; Li Y; Jin Z; Xu W; Ji Z
Aging (Albany NY); 2022 Dec; 14(24):10107-10124. PubMed ID: 36585925
[TBL] [Abstract][Full Text] [Related]
32. TMEM44 as a Novel Prognostic Marker for Kidney Renal Clear Cell Carcinoma is Associated with Tumor Invasion, Migration and Immune Infiltration.
Tian J; Sun L; Wan L; Zou H; Chen J; Liu F
Biochem Genet; 2024 Apr; 62(2):1200-1215. PubMed ID: 37561335
[TBL] [Abstract][Full Text] [Related]
33. Single-cell landscape and spatial transcriptomic analysis reveals macrophage infiltration and glycolytic metabolism in kidney renal clear cell carcinoma.
Wen CY; Hsiao JH; Tzeng YT; Chang R; Tsang YL; Kuo CH; Li CJ
Aging (Albany NY); 2023 Oct; 15(20):11298-11312. PubMed ID: 37847178
[TBL] [Abstract][Full Text] [Related]
34. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
35. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
Tang YF; Qiao B; Huang YB; Wang M
Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
[No Abstract] [Full Text] [Related]
36. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
37. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.
Wang Y; Liu S; Chen Y; Zhu B; Xing Q
World J Oncol; 2022 Feb; 13(1):27-37. PubMed ID: 35317332
[TBL] [Abstract][Full Text] [Related]
38. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment.
Wang C; He Y; Zheng J; Wang X; Chen S
Front Immunol; 2023; 14():1130513. PubMed ID: 37153569
[TBL] [Abstract][Full Text] [Related]
39. APPL1 Is a Prognostic Biomarker and Correlated with Treg Cell Infiltration via Oxygen-Consuming Metabolism in Renal Clear Cell Carcinoma.
Yang M; Gong C; Song K; Huang N; Chen H; Gong H; Yang Y; Guo S; Xiao H
Oxid Med Cell Longev; 2023; 2023():5885203. PubMed ID: 36846720
[TBL] [Abstract][Full Text] [Related]
40. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]